PROTAGONIST THERAPEUTICS INC's ticker is PTGX and the CUSIP is 74366E102. A total of 67 filers reported holding PROTAGONIST THERAPEUTICS INC in Q4 2018. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2023 | $2,007,587 | -56.3% | 72,686 | -63.6% | 0.00% | -60.0% |
Q1 2023 | $4,588,868 | +123.7% | 199,516 | +6.1% | 0.01% | +150.0% |
Q4 2022 | $2,051,473 | +70.1% | 188,036 | +31.4% | 0.00% | +100.0% |
Q3 2022 | $1,206,000 | -18.5% | 143,075 | +230.5% | 0.00% | 0.0% |
Q4 2021 | $1,480,000 | -27.9% | 43,286 | -62.7% | 0.00% | -50.0% |
Q3 2021 | $2,054,000 | -81.6% | 115,913 | -53.3% | 0.00% | -80.0% |
Q2 2021 | $11,141,000 | +114.0% | 248,235 | +23.5% | 0.01% | +100.0% |
Q1 2021 | $5,205,000 | -23.4% | 200,980 | -40.3% | 0.01% | -16.7% |
Q4 2020 | $6,791,000 | -34.2% | 336,856 | -36.2% | 0.01% | -45.5% |
Q3 2020 | $10,320,000 | -28.1% | 527,833 | -35.1% | 0.01% | -35.3% |
Q2 2020 | $14,356,000 | +624.7% | 812,946 | +189.8% | 0.02% | +466.7% |
Q1 2020 | $1,981,000 | -34.7% | 280,534 | -34.8% | 0.00% | 0.0% |
Q4 2019 | $3,035,000 | -23.5% | 430,517 | +30.4% | 0.00% | -40.0% |
Q3 2019 | $3,966,000 | -17.6% | 330,169 | -16.9% | 0.01% | -16.7% |
Q2 2019 | $4,811,000 | +48.5% | 397,278 | +54.1% | 0.01% | +50.0% |
Q1 2019 | $3,239,000 | +2353.8% | 257,728 | +1211.9% | 0.00% | – |
Q4 2018 | $132,000 | +14.8% | 19,645 | +75.5% | 0.00% | – |
Q3 2018 | $115,000 | -65.9% | 11,195 | -77.7% | 0.00% | – |
Q2 2018 | $337,000 | -48.2% | 50,261 | +60.8% | 0.00% | -100.0% |
Q4 2017 | $650,000 | – | 31,251 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
JOHNSON & JOHNSON | 2,449,183 | $19,373,000 | 4.95% |
Bain Capital Life Sciences Investors, LLC | 2,260,572 | $17,881,000 | 2.10% |
Finepoint Capital LP | 735,126 | $5,815,000 | 2.01% |
Altium Capital Management LP | 365,100 | $2,888,000 | 1.16% |
RTW INVESTMENTS, LP | 4,794,499 | $37,924,000 | 0.98% |
Amitell Capital Pte Ltd | 50,129 | $397,000 | 0.90% |
COWEN AND COMPANY, LLC | 1,065,724 | $8,430,000 | 0.81% |
Tri Locum Partners LP | 155,000 | $1,226,000 | 0.50% |
BVF INC/IL | 1,106,838 | $8,755,000 | 0.42% |
HighVista Strategies LLC | 46,459 | $367,000 | 0.22% |